Moreover, the HGF/SF model system revealed prototypical MSG activity for NME1 and/or NME2 for the first time in an in vivo setting of melanoma, with suppression of metastasis in the absence of an effect on primary tumor growth. This evidence concerns the gene NME2 and melanoma.